Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

↗ Live URL (may be dead)

Document text

Principal Investigator: Yogesh K Gupta
Organization: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Fiscal Year: 2021
Award: $608,161
Funding agency: National Institute of Allergy and Infectious Diseases

ABSTRACT
The massive global pandemic with high morbidity and mortality makes Severe Acute Respiratory Syndrome
coronavirus-2 (SARS-CoV-2) one of the deadliest viruses in recent history. It is especially noteworthy for
hijacking the normal operations of human cells. To develop effective therapies, we need a better understanding
of the mechanisms that permit the virus to invade cells and evade host immune restriction. SARS-CoV-2 encodes
the non-structural protein (nsp)16/nsp10 protein complex that transfers a methyl group from S-adenosyl
methionine (SAM) to 2’-OH of the first transcribing nucleotide of the viral mRNA and thus converts the Cap-0
(m7GpppA) to Cap-1 (m7GpppAm). The resulting viral mRNA mimics host cell’s mRNA. In this way, a cell cannot
distinguish between its own RNA and that of the virus. This modification of the virally encoded mRNA not only
tricks the immune system and helps the virus to take over the host translation machinery for synthesis of its own
proteins for survival and propagation. Ablation of nsp16 activity should trigger an immune response to viral
infection and limit pathogenesis. Our recent paper in Nature Communications described atomic level details of
the nsp16/nsp10 complex and how the enzyme is well adapted to bind the RNA cap and exert the 2’-OH
methylation. We also discovered a distant pocket (located 25Å away from the catalytic center) in nsp16 that is
unique to SARS-CoV-2. We also found that this pocket in nsp16 is partially composed of amino acids that are
unique to SARS-CoV-2. It can bind small molecules outside of the catalytic center. We propose to build a long-
term research program aimed at deciphering the factors crucial to the maintenance of RNA genome and evasion
from the host’s immune response. Our studies will reveal basic principles underlying SARS-CoV-2 RNA cap
modification, the mode of nucleoprotein (NP) assembly, interplay with mRNA, and new approaches for
therapeutic targeting. In Aim 1, we will resolve a series of new structures of nsp16/nsp10 proteins captured in
every step of the methyl transfer by X-ray crystallography. The structural data will be validated by detailed
biochemical and biophysical studies. We will resolve the biochemical and structural determinants of the assembly
of viral RNA capping machinery, and identify factors underlying integrity of RNA genome. In Aim 2, we will
develop a novel molecular tool to study temporal distribution of the RNA methylation during viral infection. We
will examine new models for combinatorial inhibition of viral proteins by drug repurposing or novel small
molecules. Finally, we will use our recently established reverse genetics approaches based on the use of a
bacterial artificial chromosome (BAC) to generate recombinant (r)SARS-CoV2 containing mutations in nsp16 to
determine their contribution in viral replication in cultured cells and pathogenesis in vivo using our recently
described K18 human angiotensin converting enzyme 2 (hACE2) mouse model of SARS-CoV-2 infection and
associated coronavirus disease 2019 (COVID-19).

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><5' Capped RNA><5' mRNA Cap Structure><ACE2><AI system><Ablation><Active Sites><Address><Amino Acids><Architecture><Artificial Intelligence><Assay><BAC clone><BACs><Bacterial Artificial Chromosomes><Bats><Binding><Bioassay><Biochemical><Biologic Assays><Biological Assay><Biology><Biophysics><COVID-19><COVID-19 therapeutics><COVID-19 therapy><COVID-19 treatment><COVID-19 virus><COVID19><COVID19 therapeutics><COVID19 therapy><COVID19 treatment><COVID19 virus><CV-19><CV19><Cell Body><Cells><Chiroptera><CoV-2><CoV2><Communication><Complex><Computer Reasoning><ConvNet><Coronaviridae><Coronavirus><Crystallization><Cultured Cells><Dangerousness><Data><Disease><Disorder><Distant><Economics><Engineering / Architecture><Enzyme Gene><Enzymes><Epidemiological data><Epidemiology data><Future><Generalized Growth><Genetic Alteration><Genetic Change><Genetic defect><Genome><Genomic approach><Growth><Health><History><Human><Immune><Immune Evasion><Immune response><Immune system><Immunes><Immunological response><Individual><Infection><Innate Immune Response><Invaded><Investigation><K-18><K-18 conjugate><K18><K18 combination><Length><Libraries><Life Cycle><Life Cycle Stages><Machine Intelligence><Maintenance><Maps><Messenger RNA><Methods><Methylation><Mice><Mice Mammals><Modeling><Modern Man><Modification><Molecular><Molecular Configuration><Molecular Conformation><Molecular Interaction><Molecular Stereochemistry><Morbidity><Morbidity - disease rate><Murine><Mus><Mutation><Nature><Non-Polyadenylated RNA><Non-structural Protein><Nonstructural Protein><Nucleoproteins><Nucleotides><Organism><Paper><Pathogenesis><Property><Proteins><Publishing><RNA><RNA Binding><RNA Caps><RNA Degradation><RNA Folding><RNA Gene Products><RNA Processing><RNA Viruses><RNA bound><RNA chemical synthesis><RNA methylation><RNA synthesis><Recombinants><Recording of previous events><Reporting><Research><Ribonucleic Acid><S-Adenosylhomocysteine><S-adenosyl-methionine><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV-2><SARS-CoV-2 therapeutics><SARS-CoV-2 therapy><SARS-CoV-2 treatment><SARS-CoV2><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 therapeutics><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Series><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 therapeutics><Severe acute respiratory syndrome related corona virus 2><Single Crystal Diffraction><Solid><Specificity><Structure><Structure-Activity Relationship><Surface><Technology><Testing><Time><Tissue Growth><Translations><UTRs><Untranslated Regions><Viral><Viral Diseases><Viral Gene Products><Viral Gene Proteins><Viral Genome><Viral Pathogenesis><Viral Proteins><Virion><Virus><Virus Assembly><Virus Diseases><Virus Particle><Virus Replication><Wuhan coronavirus><X Ray Crystallographies><X-Ray Crystallography><X-Ray Diffraction Crystallography><X-Ray/Neutron Crystallography><Xray Crystallography><allergic/immunologic body system><allergic/immunologic organ system><aminoacid><analog><angiotensin converting enzyme 2><angiotensin converting enzyme II><base><beta CoV><beta coronavirus><betaCoV><betacoronavirus><biophysical analysis><biophysical foundation><biophysical principles><biophysical sciences><biophysical studies><chemical library><chemical structure function><combinatorial><conformation><conformational state><convolutional network><convolutional neural nets><convolutional neural network><corona virus><corona virus disease 2019><coronavirus disease 2019><coronavirus disease 2019 therapeutics><coronavirus disease 2019 therapy><coronavirus disease 2019 treatment><coronavirus disease 2019 virus><develop a vaccine><development of a vaccine><drug candidate><drug repurposing><effective therapy><effective treatment><epidemiologic data><genetic approach><genetic strategy><genome mutation><genomic effort><genomic strategy><hCoV19><host response><immune system response><immunoresponse><improved><in vitro testing><in vivo><innovate><innovation><innovative><life course><living system><mRNA><methyl group><mortality><mouse model><murine model><nCoV2><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><novel><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><ontogeny><operation><pandemic><pandemic disease><programs><protein complex><repurposing agent><repurposing medication><reverse genetics><screening><severe acute respiratory syndrome coronavirus 2 therapy><severe acute respiratory syndrome coronavirus 2 treatment><severe acute respiratory syndrome-CoV><small molecule><small molecule libraries><stem><structure function relationship><therapeutic target><therapeutics against COVID-19><therapeutics against COVID19><therapeutics against SARS-CoV-2><therapeutics against SARS-coronavirus-2><therapeutics against Severe acute respiratory syndrome coronavirus 2><therapeutics against coronavirus disease 2019><therapeutics for novel coronavirus><tool><transcriptomics><treat COVID-19><treat COVID19><treat SARS-CoV-2><treat coronavirus disease 2019><treat severe acute respiratory syndrome coronavirus 2><vaccine development><vaccine formulation><viral RNA><viral assembly><viral infection><viral multiplication><viral replication><virus RNA><virus genome><virus infection><virus multiplication><virus pathogenesis><virus protein><virus-induced disease><β CoV><β coronavirus><βCoV>